Synopsis of recent research by authors named "Rinki Deo"
- Rinki Deo's recent research focuses on the prevalence and implications of SARS-CoV-2 resistance to antiviral treatments, particularly how it affects virologic rebound and patient outcomes after monoclonal antibody therapy.
- Key findings indicate that antiviral resistance mutations often emerge during treatment, influencing the efficacy of therapies such as nirmatrelvir and monoclonal antibodies, which may lead to prolonged infections in certain populations, especially in immunocompromised patients.
- The studies also highlight the complexities of immune responses to SARS-CoV-2 and the varying kinetics of viral clearance based on the type of monoclonal antibody treatment and the characteristics of the infecting virus variant, particularly among different demographic groups.
